中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2011年
7期
439-441
,共3页
赵伟平%张志根%李新德%余大敏%李恭会%芮雪芳%丁国庆%汪强
趙偉平%張誌根%李新德%餘大敏%李恭會%芮雪芳%丁國慶%汪彊
조위평%장지근%리신덕%여대민%리공회%예설방%정국경%왕강
肾疾病,囊性%癌,肾细胞%Hippel-Lindau病%基因%突变
腎疾病,囊性%癌,腎細胞%Hippel-Lindau病%基因%突變
신질병,낭성%암,신세포%Hippel-Lindau병%기인%돌변
Kidney diseases,cystic%Carcinoma,renal cell%Hippel-Lindau disease%Genes%Mutation
目的 提高对多房囊性肾细胞癌(MCRCC)的认识及诊治水平,分析MCRCC中von Hippel-Lindau(VHL)基因的作用.方法 回顾性分析2000-2010年17例MCRCC患者资料,占同期收治512例肾癌的3.32%.男11例,女6例.年龄37~61岁,平均46岁.术前常规行B超、CT等检查,误诊为肾盂旁囊肿1例.应用PCR、PCR产物直接测序等方法分析11例MCRCC组织和相应远离病灶的正常组织中VHL基因突变的情况.结果 17例患者行根治性肾切除术14例,其中1例先行囊肿去顶术,术中囊壁组织冰冻病理检查提示透明细胞癌,改行根治性肾切除术;行肾部分切除术3例.肿瘤直径2.2~6.0 cm,平均(3.6±1.2)cm.术后病理均为MCRCC,镜下主要表现为纤维囊壁组织内衬单层或数层肿瘤细胞,核小致密,胞质透亮.TNM分期均为T1N0M0,病理分级G1 14例,G2 3例.术后随访9~36个月,平均12个月,均未见复发及转移.11例MCRCC组织中7例(64%)存在VHL基因突变,而正常组织标本均未发现VHL基因突变.结论 MCRCC作为肾细胞癌的一种少见的独立亚型,病理及临床上易漏诊或误诊.CT等影像学检查有助于术前诊断,因其预后良好,手术方式推荐保留肾单位手术.VHL基因突变与MCRCC的发生存在一定关系.
目的 提高對多房囊性腎細胞癌(MCRCC)的認識及診治水平,分析MCRCC中von Hippel-Lindau(VHL)基因的作用.方法 迴顧性分析2000-2010年17例MCRCC患者資料,佔同期收治512例腎癌的3.32%.男11例,女6例.年齡37~61歲,平均46歲.術前常規行B超、CT等檢查,誤診為腎盂徬囊腫1例.應用PCR、PCR產物直接測序等方法分析11例MCRCC組織和相應遠離病竈的正常組織中VHL基因突變的情況.結果 17例患者行根治性腎切除術14例,其中1例先行囊腫去頂術,術中囊壁組織冰凍病理檢查提示透明細胞癌,改行根治性腎切除術;行腎部分切除術3例.腫瘤直徑2.2~6.0 cm,平均(3.6±1.2)cm.術後病理均為MCRCC,鏡下主要錶現為纖維囊壁組織內襯單層或數層腫瘤細胞,覈小緻密,胞質透亮.TNM分期均為T1N0M0,病理分級G1 14例,G2 3例.術後隨訪9~36箇月,平均12箇月,均未見複髮及轉移.11例MCRCC組織中7例(64%)存在VHL基因突變,而正常組織標本均未髮現VHL基因突變.結論 MCRCC作為腎細胞癌的一種少見的獨立亞型,病理及臨床上易漏診或誤診.CT等影像學檢查有助于術前診斷,因其預後良好,手術方式推薦保留腎單位手術.VHL基因突變與MCRCC的髮生存在一定關繫.
목적 제고대다방낭성신세포암(MCRCC)적인식급진치수평,분석MCRCC중von Hippel-Lindau(VHL)기인적작용.방법 회고성분석2000-2010년17례MCRCC환자자료,점동기수치512례신암적3.32%.남11례,녀6례.년령37~61세,평균46세.술전상규행B초、CT등검사,오진위신우방낭종1례.응용PCR、PCR산물직접측서등방법분석11례MCRCC조직화상응원리병조적정상조직중VHL기인돌변적정황.결과 17례환자행근치성신절제술14례,기중1례선행낭종거정술,술중낭벽조직빙동병리검사제시투명세포암,개행근치성신절제술;행신부분절제술3례.종류직경2.2~6.0 cm,평균(3.6±1.2)cm.술후병리균위MCRCC,경하주요표현위섬유낭벽조직내츤단층혹수층종류세포,핵소치밀,포질투량.TNM분기균위T1N0M0,병리분급G1 14례,G2 3례.술후수방9~36개월,평균12개월,균미견복발급전이.11례MCRCC조직중7례(64%)존재VHL기인돌변,이정상조직표본균미발현VHL기인돌변.결론 MCRCC작위신세포암적일충소견적독립아형,병리급림상상역루진혹오진.CT등영상학검사유조우술전진단,인기예후량호,수술방식추천보류신단위수술.VHL기인돌변여MCRCC적발생존재일정관계.
Objective To discuss the diagnosis and surgical management of multilocular cystic renal cell carcinoma (MCRCC) and to evaluate the gene function of the mutation of von Hippel-Lindau (VHL) gene in MCRCC. Methods Seventeen MCRCC cases (11 men and 6 women) out of 512 cases of renal cell carcinoma from 2000 to 2010 were retrospectively analyzed. The mean age of the 17 patients was 46 years (37-61 years). Ultrasonography and CT were available in all 17 cases, and 1 case was misdiagnosed as parapelvic renal cyst. The mutation of VHL gene was detected by PCR in the specimens of can-cerous tissue and adjacent normal tissue from 11 cases of MCRCC. Results Three of 17 cases underwent nephron sparing surgery, the others underwent radical nephrectomy. One case underwent unroofing of parapelvic renal cyst, but the rapid frozen pathology of the cyst wall showed renal cell carcinoma of clear type. As a result, radical nephrectomy was eventually performed. All 17 cases were confirmed as MCRCC by eva-luating pathological characteristics, such as the cyst wall lined by single or several layers of clear tumor cells and the nuclei which were small and anachromasis. Clinical stages of all cases were T1N0M0, in which there were 14 cases with pathological T1G1 and 3 cases with pathological T1G2. All patients underwent a follow-up of 9 to 36 months (mean, 12 months) without recurrence or metastasis. Mutation of VHL gene was detected in 7 of 11 cases (64%), but all adjacent normal tissues were negative. Conclusions As a rare subtype of renal cell carcinoma, MCRCC is difficult to diagnose. CT is an essential measure in diagnosis of MCRCC preoperatively. Because of the good prognosis of reported cases, nephron sparing surgery for the treatment of MCRCC is recommended. VHL gene mutations may play an important role in the carcinogenesis of MCRCC.